Comparison of ETCO2 detectable Nasopharyngeal Airway Device and nasal cannula during Anesthesia for pediatric Gastroscopy: a randomized controlled trial

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800018282

Enrollment

Unknown

Registered

2018-09-08

Start date

2018-09-17

Completion date

Unknown

Last updated

2018-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia for pediatric Gastroscopy

Interventions

NPA group: ETCO2 detectable Nasopharyngeal Airway Device

NC group:nasal cannula

Eligibility

Sex/Gender

All

Age

2 Years to 10 Years

Inclusion criteria

Inclusion criteria: children aged 2–12 years scheduled for gastroscopy in our endoscopy center.

Exclusion criteria

Exclusion criteria: nasopharyngeal diseases, bleeding, trauma, inflammation,severe cardiovascular or pulmonary diseases.

Design outcomes

Primary

Measure	Time frame
incidence of hypoxemia;	—

Countries

China

Contacts

Public Contacthuanglei

KunMing Children's Hospital

65255106@qq.com+86 18087347480

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026